2019
DOI: 10.1016/j.gene.2019.03.049
|View full text |Cite
|
Sign up to set email alerts
|

Prediction of new vaccine targets in the core genome of Corynebacterium pseudotuberculosis through omics approaches and reverse vaccinology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
21
0
4

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 31 publications
(25 citation statements)
references
References 76 publications
0
21
0
4
Order By: Relevance
“…This approach is characterized by the classification of genes in three groups: the core genome, which is composed by genes shared by all strains; the accessory genome, which is composed by genes absent in some strains; and the strain-specific genes (Tettelin et al, 2005). Given this, the analysis of genes belonging to the core genome is particularly important, once the presence of orthologues shared by all strains of a biovar can reveal interesting objects of study in the search for new therapeutic or vaccine targets for CLA (Araújo et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…This approach is characterized by the classification of genes in three groups: the core genome, which is composed by genes shared by all strains; the accessory genome, which is composed by genes absent in some strains; and the strain-specific genes (Tettelin et al, 2005). Given this, the analysis of genes belonging to the core genome is particularly important, once the presence of orthologues shared by all strains of a biovar can reveal interesting objects of study in the search for new therapeutic or vaccine targets for CLA (Araújo et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…Only recently such genomic features are being taken into consideration when performing RV, as has been shown for Helicobacter pylori (13), Acinetobacter baumanii (14), Leptospira interrogans (15), pathogenic Brucella spp. (16), and Corynebacterium pseudotuberculosis (17). While these analyses provided the complete decision-tree performed, none of them provided the in-house scripts used for integration of all tools employed in their approaches.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, there are no reliable tests available to diagnose all CL cases. ELISA, using several antigenic preparations, has already been tested (Sutherland et al 1987;Menzies et al 1994;Sting et al 1998;Carminati et al 2003); however, few formulations use recombinant proteins (Menzies et al 1994;Rezende et al 2016; Barral et al 2019;Silva et al 2019). This strategy could signi cantly increase sensitivity and speci city due to the use of a single puri ed antigen (Rezende et al 2016).…”
Section: Introductionmentioning
confidence: 99%
“…The complete sequencing of the C. pseudotuberculosis genome, combined with the introduction of more advanced technologies, such as mass spectrometry, brought new perspectives to the study of proteins excreted by microorganisms as potential therapeutic, vaccine, or immunoassay targets (D'Afonseca et al 2010;Bastos et al 2012;Araújo et al 2019). Some of the highlighted immunoassay and vaccine development target proteins include diptheric toxin repressor homologue (DTxR), Trx and TrxR thioredoxin complex proteins, LexA proteins, superoxide dismutase-C (SodC), SpaC, neuraminidase H (NanH), and PknG serine/threonine kinases (Trost et al 2010;Hall et al 2011;Lin et al 2016;Santana-Jorge et al 2016).…”
Section: Introductionmentioning
confidence: 99%